Paramyxoviruses are the most important cause of respiratory disease in children. The long-term objectives of this project are to elucidate the structural, molecular, and biological determinants of paramyxovirus host tropism, virulence, and protective immunity using Sendai virus, an archetypal paramyxovirus. To this end the proposed studies are focused on the role of the hemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins of the virion.
The specific aims are: (1) characterization of biologically active fragments of HN and F with potential for crystallization, (2) to locate on the primary amino acid sequence the epitopes that define the antigenic structure and functions of HN and F, and (3) to determine the influence of host cells and immune-pressure on the selection of Sendai virus populations with altered host range and virulence. To prepare biologically active fragments of HN and F with a possibility for crystallization and x-ray analyses, the hydrophobic terminus will be removed by proteolysis. The cleavage product will be purified by ion exchange chromatography and rate zonal centrifugation. Before attempting crystallization, the cleaved proteins will be examined for retention of biological activities; neuraminidase for HN and antibody binding for both HN and F. Amino acid sequence analysis will determine the precise point of cleavage. Crystallization of an antigen-monoclonal antibody complex will be attempted and served as an alternative method to produce analyzable crystals and as a way to analyze their molecular interaction. Second, monoclonal antibodies will be used to map the antigenic structure and determine the functional activities of HN and F. Nucleotide sequence analysis of antigenic variants selected with the monoclonal antibodies will localize antigenic and functional sites on the primary amino acid sequence. This information will be correlated with the structural information. Third, Sendai virus primary isolates will be grown in mammalian and avian cells. The viruses will be characterized with monoclonal antibodies to the surface glycoproteins to determine whether antigenically distinguishable viruses are selected in different host cells. Antigenic changes will be correlated with sequence changes in the HN and F molecules and alterations in the host tropism and virulence.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI011949-15
Application #
3125070
Study Section
Virology Study Section (VR)
Project Start
1978-07-01
Project End
1992-08-31
Budget Start
1989-09-01
Budget End
1990-08-31
Support Year
15
Fiscal Year
1989
Total Cost
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
Hurwitz, Julia L (2008) Development of recombinant Sendai virus vaccines for prevention of human parainfluenza and respiratory syncytial virus infections. Pediatr Infect Dis J 27:S126-8
Zaitsev, Viatcheslav; von Itzstein, Mark; Groves, Darrin et al. (2004) Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol 78:3733-41
Connaris, Helen; Takimoto, Toru; Russell, Rupert et al. (2002) Probing the sialic acid binding site of the hemagglutinin-neuraminidase of Newcastle disease virus: identification of key amino acids involved in cell binding, catalysis, and fusion. J Virol 76:1816-24
Takimoto, Toru; Taylor, Garry L; Connaris, Helen C et al. (2002) Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J Virol 76:13028-33
Bousse, Tatiana; Matrosovich, Tatyana; Portner, Allen et al. (2002) The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction. J Virol 76:8244-51
Takimoto, T; Murti, K G; Bousse, T et al. (2001) Role of matrix and fusion proteins in budding of Sendai virus. J Virol 75:11384-91
Coronel, E C; Takimoto, T; Murti, K G et al. (2001) Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. J Virol 75:1117-23
Suzuki, T; Portner, A; Scroggs, R A et al. (2001) Receptor specificities of human respiroviruses. J Virol 75:4604-13
Bousse, T; Takimoto, T; Matrosovich, T et al. (2001) Two regions of the P protein are required to be active with the L protein for human parainfluenza virus type 1 RNA polymerase activity. Virology 283:306-14
Takimoto, T; Taylor, G L; Crennell, S J et al. (2000) Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virology 270:208-14

Showing the most recent 10 out of 48 publications